| |
| |
|
| Insider
Information: |
El Coronado Holdings, Llc |
| Relationship: |
10% Owner |
| City: |
Pearce |
| State: |
AZ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
6,674,725 |
|
|
Indirect Shares
|
27,131,085 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$10,998,072 |
|
|
| Total
Shares |
33,805,810 |
|
|
| Total
Value |
$10,998,072 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nmi Health Inc |
NANM |
10% Owner |
2005-03-02 |
0 |
2009-06-22 |
9,805,857 |
Premium* |
|
|
Novogen Limited (ADR) |
NVGN |
10% Owner |
2006-04-21 |
0 |
2013-11-05 |
385,749 |
Premium* |
|
|
Chelsea Therapeutics Internation... |
CHTP |
10% Owner |
2007-03-22 |
0 |
2012-12-17 |
6,432,673 |
Premium* |
|
|
MEI Pharma Inc |
MEIP |
10% Owner |
2012-12-03 |
0 |
2012-12-03 |
3,832,081 |
Premium* |
|
|
Protea Biosciences Group Inc |
PRGB |
10% Owner |
2013-12-30 |
6,674,725 |
2013-12-30 |
6,674,725 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
289 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NANM |
Nmi Health Inc |
10% Owner |
– – • |
2005-02-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
| NANM |
Nmi Health Inc |
10% Owner |
– – • |
2005-02-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,389,500 |
|
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-03-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,536,304 |
|
- |
|
| MEIP |
MEI Pharma Inc |
10% Owner |
– – • |
2012-12-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,832,081 |
|
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2012-12-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,136,044 |
|
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2012-12-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,136,044 |
|
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-05-23 |
4 |
B |
$5.29 |
$16 |
I/I |
3 |
2,846,249 |
1.42 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2008-04-09 |
4 |
B |
$4.85 |
$1,373 |
I/I |
283 |
4,344,563 |
1.42 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-03-08 |
4 |
B |
$10.00 |
$3,000 |
I/I |
300 |
2,264,273 |
1.42 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-06-06 |
4 |
B |
$5.08 |
$2,540 |
I/I |
500 |
2,956,756 |
1.42 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2013-02-26 |
4 |
S |
$8.00 |
$4,000 |
I/I |
(500) |
626,196 |
0 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-03-20 |
4 |
B |
$9.64 |
$5,304 |
I/I |
550 |
2,273,614 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2006-11-28 |
4 |
B |
$9.91 |
$5,946 |
I/I |
600 |
2,158,373 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2006-06-01 |
4 |
B |
$9.86 |
$9,495 |
I/I |
963 |
2,125,366 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2010-04-08 |
4 |
B |
$3.72 |
$3,608 |
I/I |
970 |
8,058,970 |
1.42 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2008-04-03 |
4 |
B |
$4.86 |
$4,860 |
I/I |
1,000 |
4,341,280 |
1.42 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2008-04-07 |
4 |
B |
$4.83 |
$4,830 |
I/I |
1,000 |
4,342,280 |
1.42 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-06-07 |
4 |
B |
$9.20 |
$9,241 |
I/I |
1,005 |
2,427,060 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2006-05-31 |
4 |
B |
$9.75 |
$10,725 |
I/I |
1,100 |
2,124,403 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2013-10-29 |
4 |
S |
$6.04 |
$6,641 |
I/I |
(1,100) |
435,071 |
0 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-03-19 |
4 |
B |
$9.64 |
$11,645 |
I/I |
1,208 |
2,273,064 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2008-04-16 |
4 |
B |
$4.63 |
$6,019 |
I/I |
1,300 |
4,347,580 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2009-05-15 |
4 |
B |
$2.80 |
$3,920 |
I/I |
1,400 |
6,500,887 |
1.42 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-04-10 |
4 |
B |
$9.98 |
$15,070 |
I/I |
1,510 |
2,348,240 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-06-18 |
4 |
B |
$8.30 |
$13,986 |
I/I |
1,685 |
2,454,918 |
1.5 |
- |
|
289 Records found
|
|
Page 1 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
